Q3 2025 Performance - Net sales reached $70.7 million, a decrease of 10.3% year-over-year[11] - Consumables net sales were $49.8 million, a decrease of 2.6% year-over-year, but would have increased modestly excluding the China distributor transition[11] - Delivery systems net sales were $20.8 million, a decrease of 24.6% year-over-year due to macroeconomic challenges[11] - Adjusted EBITDA was $8.9 million, an increase year-over-year due to lower operational spend partially offset by lower adjusted gross profit[11] - Net loss was $(11.0) million, an improvement of $7.3 million year-over-year due to lower operational spend and higher gross margin, partially offset by lower net sales[11] Financial Guidance - The company estimates Q4 2025 net sales to be between $74.5 million and $81.5 million[14] - The company projects Q4 2025 adjusted EBITDA to be between $6.9 million and $8.9 million[14] - The company forecasts FY 2025 net sales to be between $293 million and $300 million[14] - The company anticipates FY 2025 adjusted EBITDA to be between $37 million and $39 million[14] Market Position - Hydrafacial holds the 1 market share, with 41% of aesthetic practices with microdermabrasion offering Hydrafacial[18] - Hydrafacial has a 64% market share in the U S microdermabrasion category[42]

Q2 2025 Performance - Net sales decreased by 13.7% year-over-year to $78.2 million[10] - Delivery Systems net sales decreased by 36.5% year-over-year to $22.4 million[10] - Consumables net sales increased slightly by 0.8% year-over-year to $55.8 million[10] - Net income increased by $19.5 million year-over-year to $19.7 million[10] - Adjusted EBITDA increased by $19.1 million year-over-year to $13.9 million[10] Financial Outlook - The company expects 3Q 2025E net sales to be between $65 million and $70 million[20] - The company expects 3Q 2025E adjusted EBITDA to be between $2 million and $4 million[21] - The company expects FY 2025E net sales to be between $285 million and $300 million[21] - The company expects FY 2025E adjusted EBITDA to be between $27 million and $35 million[21] Market Position - Hydrafacial holds the 1 market share and 41% of aesthetic practices with microdermabrasion offer Hydrafacial[25] - Hydrafacial is the 2 best-known brand[26]

Core Insights - The Beauty Health Company has launched the Hydrafacial HydraFillic with Pep9™ Booster, a new skin treatment designed to visibly improve fine lines, wrinkles, and overall skin health through a proprietary complex of nine peptides [1][19] - The product aims to meet the rising consumer demand for non-invasive treatments that address aging signs and enhance skin health, as 81% of beauty consumers prioritize fine lines and wrinkles as their main skin concern [2][3] Product Details - The HydraFillic with Pep9™ Booster is clinically proven to enhance skin appearance, hydration, and barrier strength, resulting in a firmer and more youthful complexion [1][19] - Clinical testing showed significant improvements in skin firmness (100%), overall glow (96%), and reduced appearance of fine lines (83%) among participants after treatment [6][9] - Key ingredients include a proprietary complex of nine peptides, Triple Hyaluronic Acid Complex, and fruit extracts, which work synergistically to improve skin hydration and minimize aging signs [7][8] Market Context - The launch reflects the company's commitment to innovation in non-invasive aesthetic treatments, leveraging advanced device technology and novel skincare formulations [1][3] - The HydraFillic with Pep9™ Booster is positioned to empower providers to customize treatments based on individual client needs, aligning with current aesthetic trends focused on longevity and skin health [2][4]